Transdermal Glutathione Patch Using Penetration Enhancers
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for a transdermal delivery system for glutathione to effectively reduce nausea and other side effects in patients, particularly those unable to take antioxidants and vitamins in conventional forms, while minimizing adverse reactions and improving absorption.
Innovation Solution
A transdermal formulation combining glutathione with Vitamin D, arnica, glycol, a buffer, and a base cream, applied as a latex-free hypoallergenic adhesive patch or cream, which enhances the permeation of active antioxidant agents and avoids common side effects by localized application, allowing for better absorption and reduced systemic drug concentrations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If glutathione is administered orally or via injection, then therapeutic effects are achieved, but nausea and other side effects occur
Solution Approach 1:
The patent uses a transdermal delivery system as an intermediary pathway between the glutathione formulation and the patient's system. The formulation includes penetration enhancers (isopropyl myristate, dimethyl sulfoxide) that mediate the transfer of glutathione through the skin barrier, avoiding direct gastrointestinal or intravenous contact that causes nausea. The adhesive patch serves as a physical intermediary that controls localized delivery.
Solution Approach 2:
The patent replaces the mechanical/administrative systems of oral ingestion or injection with a topical application system. Instead of forcing the substance through the digestive tract or bloodstream via injection, the formulation uses chemical penetration enhancers and transdermal absorption to deliver glutathione systemically through the skin, eliminating the mechanical trauma and associated side effects.
2Reliability
If conventional forms of antioxidants and vitamins are taken, then therapeutic benefits are obtained, but absorption limitations and side effects occur
Solution Approach 1:
The patent changes the physical and chemical parameters of the delivery system by using a transdermal route instead of oral administration. The formulation modifies parameters such as pH (using sodium bicarbonate buffer), viscosity (using base cream), and incorporates penetration enhancers to optimize transdermal absorption. This parameter transformation bypasses gastrointestinal absorption limitations.
Solution Approach 2:
The patent creates a composite formulation combining glutathione with multiple auxiliary substances: Vitamin D (to enhance absorption), arnica (for skin penetration), glycol (humectant and penetration enhancer), buffer (pH control), base cream (vehicle), isopropyl myristate (penetration enhancer), and dimethyl sulfoxide (penetration enhancer). This composite material works synergistically to improve transdermal delivery efficiency.
3Reliability
If higher concentrations of drugs are used to improve efficacy, then therapeutic effects increase, but adverse reactions and side effects increase
Solution Approach 1:
The patent applies the formulation locally to the skin surface through an adhesive patch, creating a localized high concentration at the application site that gradually releases systemically. This local application allows for higher effective concentrations at the delivery interface without causing systemic adverse reactions, as the penetration enhancers and controlled release through the skin moderate the overall systemic exposure.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The transdermal formulation effectively reduces nausea, improves sleep quality, increases energy, reduces wrinkles and joint pain, and enhances skin moisture retention without the need for injections or oral supplementation, while minimizing side effects and providing preventive care against aging and cancer.
Implementation Method 1
a base cream resilient in the presence of a wide range of drugs while increasing permeation of active antioxidant agents
Implementation Method 2
a buffer and a base cream
Data Source
AI summary
A transdermal formulation which can be applied to the skin as a latex-free hypoallergenic adhesive patch or transdermal delivery cream using a combination of glutathione, Vitamin D, glycol, sodium bicarbonate and base cream resilient in the presence of a wide range of drugs while increasing permeation of active antioxidant agents, water, isopropyl myristate, polyoxyethylene sorbitan monooleate, isopropyl palmitate, ascorbic acid, and dimethyl sulfoxide. The dosage amount can create in the patient (i) regulation of sleep, (ii) increased energy during awake periods, (iii) improved concentration during awake periods, (iv) reduction of facial wrinkles, and (v) reduction of joint and muscular pain with increases by at least 10 percent of the ability of skin to retain moisture and totally absorb the glutathione without requiring injection or oral supplementation of the glutathione.


